1st Quarter - Report

ACG ADVOCACY for GENENTECH INC

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

General Patent Reform Issues S. 23: America Invents Act H.R. 1249: Leahy-Smith America Invents Act

LobbyistCovered position, as disclosed
CHRIS ISRAEL —
IAN P MUSSELMAN —
DAVID J URBAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 23 (112th), H.R. 1249 (112th)

Health Issues HCR

Prescription Drug User Fee Act (PDUFA) Reauthorization Avastin - Use in breast cancer treatment ASP+6 Reimbursement Issues Melanoma Research Foundation Hill event

LobbyistCovered position, as disclosed
CHRIS ISRAEL Dept Asst Sec for Tech Policy, Dept of Commerce
IAN P MUSSELMAN —
DAVID J URBAN Chief of Staff, Senator Arlen Specter

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
F. HOFFMANN-LA ROCHE LTD. Switzerland Switzerland 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.